1. Home
  2. Specialties
  3. Hematology & Oncology CME
  4. Course listing
  5. Program Schedule
  6. Thursday, August 9
  1. Select a Specialty
  2. Find a Course
Hematology & Oncology

22nd Annual Mayo Clinic Hematology/Oncology Reviews

Thursday, August 9

TimeTopic
  Session: GI Malignancies
7:00 a.m. Registration and Continental Breakfast
8:00 Welcome and Pre-Test
Gerardo Colon-Otero, M.D.
  GI Cancers
Moderator: Steven Alberts, M.D.
8:20 Localized Esophageal Cancers: Initial Assessment and Endoscopic Intervention
Navtej S. Buttar, M.D.
8:40 Metastatic Esophageal and Gastric Cancers
Harry H. Yoon, M.D.
9:00 Case Presentations, Q&A, Post-Test
Stephen Ko, M.D. and Steven Alberts, M.D.
9:20 Break
  Pancreatic and Hepatobiliary Cancers
Moderator: Steven Alberts, M.D.
9:40 Localized Pancreatic Cancer
Horacio Asbun, M.D.
10:00 Hepatobiliary Cancers
Lewis Roberts, M.B., Ch.B., Ph.D.
10:20 Case Presentations, Q&A, Post-Test
Stephen Ko, M.D. and Steven Alberts, M.D.
10:40 Break
  Colorectal Cancers
Moderators: Steven Alberts, M.D. and Ron Landmann, M.D.
11:00 Adjuvant Treatment of Colon and Rectal Cancer
Joleen M. Hubbard, M.D.
11:20 Metastatic Colorectal Cancer
Steven Alberts, M.D.
11:40 Case Presentations, Q&A, Post-Test
Steven Alberts, M.D. and Ron Landmann, M.D.
Noon Lunch
  Session: Breast Cancer
Treatment of Localized Breast Cancer
Moderator: Edith Perez, M.D.
1:20 p.m. Surgery Update
Amy Degnim, M.D.
1:40 Radiation Update
Laura Vallow, M.D.
2:00 Adjuvant Systemic Treatment Update
Monica Fornier, M.D.
2:20 Case Presentations, Q&A, Post-Test
Edith Perez, M.D.
2:40 Break
  Treatment of Metastatic Breast Cancer
Moderator: Edith Perez, M.D.
3:00 Metastatic Triple Negative
Edith Perez, M.D.
3:20 Metastatic Hormone Receptor Positive
Matt Goetz, M.D.
3:40 Metastatic HER2 Positive
Karen Gelmon, M.D.
4:00 Case Presentations, Q&A, Post-Test
Edith Perez, M.D.
4:20 Adjourn
4:20 Informal Networking – Meet the Faculty and Course Organizers (Cash Bar)
5:30 Poster Presentations by Fellows
6:30 Dinner
Lessons from Clinical Trials of Targeted Therapies in Cancer
Keynote Speaker: George Sledge, M.D.